Evidence map›Paper›PMID 25271000›Full record

ArticleJournal of thrombosis and thrombolysis2015

Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma.

Maeve P Crowley, Maeve P Crowely, Shane Quinn, Eoin Coleman, Joseph A Eustace, Oonagh M Gilligan, Susan I O'Shea, Susan I O Shea

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Analysis of Coagulation Abnormality in Patients with Multiple Myeloma and Its Clinical Significance.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  11. Article
  12. Article
  13. Thrombosis Risk Associated with Head and Neck Cancer: A Review.International journal of molecular sciences · 2019
    Review
  14. Review
  15. Article
  16. Evaluation of thromboelastography in bitches with pyometra.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2018
    Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maeve P Crowley
Maeve P CrowelyDepartment of Haematology, Cork University Hospital, Wilton, Cork, Ireland, maeve.crowley@gmail.com.
Shane Quinn
Eoin Coleman
Joseph A Eustace
Oonagh M Gilligan
Susan I O'Shea
Susan I O Shea
Cork University Hospital · IEUniversity College Cork · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The link between myeloma and thrombosis is well established. Monoclonal gammopathy of undetermined significance (MGUS) has also been associated with an increased risk of thrombosis. It was recently demonstrated that patients with myeloma display changes in thromboelastometry that may indicate a prothrombotic state. There is little data with regard to changes in thromboelastography in patients with myeloma or MGUS. The aim of this study was to investigate the differing coagulation profiles of patients of patients with myeloma and MGUS by means of conventional coagulation tests and thromboelastography. Blood was taken by direct venepuncture from patients with myeloma, MGUS and normal controls. Routine coagulation tests were performed in an accredited hospital laboratory. Thromboelastography (TEG(®)) was performed as per the manufacturer's protocol. Eight patients were recruited in each group. Patients with myeloma had a significantly lower mean haemoglobin level than patients with MGUS or normal controls (p < 0.001). Patients with myeloma had a significantly more prolonged mean prothrombin time than normal controls (p = 0.018) but not patients with MGUS. Patients with myeloma had significantly higher median D-dimer levels than normal controls (p = 0.025), as did patients with MGUS (p = 0.017). Patients with myeloma had a significantly higher mean factor VIII level than normal controls (p = 0.009) and there was a non-significant trend towards patients with MGUS having higher factor VIII levels than normal controls (p = 0.059). There was no significant difference in thromboelastographic parameters between the three groups. Patients with MGUS appear to have a distinct coagulation profile which is intermediate between patients with myeloma and normal controls.

Indexed as

Blood CoagulationMonoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaThrombosisAgedBlood Coagulation TestsDiagnosis, DifferentialFactor VIIIFemaleFibrin Fibrinogen Degradation ProductsHemoglobinsHumansIrelandMaleMiddle AgedResearch DesignFactor VIIIFibrin Fibrinogen Degradation Productsfibrin fragment DHemoglobins

Identifiers

PMID25271000
OpenAlexW2083557541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.